Who founded Endoshunt?

Endoshunt was founded by Michael Finn-Henry in 2022.

Who are Endoshunt's investors?

Endoshunt's investors include New York Angels, Octerra Capital, The Innovation Space.

How much funding has Endoshunt raised?

Endoshunt has disclosed $75K raised across 1 round.

Where is Endoshunt headquartered?

Endoshunt is headquartered in Lincoln, US.

Endoshunt

Lincoln, US · Founded 2022 · 6 employees on LinkedIn · 3 known investors

Find your way into Endoshunt

Paths you didn't know you had: your email and LinkedIn already hold routes to the Endoshunt team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip. The company has functional prototypes validated in benchtop and in vivo studies and is pursuing FDA 510(k) clearance.

Hardware Healthtech Medical Devices

Founders & leadership

Endoshunt was founded in 2022 by Michael Finn-Henry.

Michael Finn-Henry President and Co-FounderMichael Finn-Henry has a background in robotics and has worked to advance multiple research projects toward commercialization. He is pursuing a PhD in mechanical engineering at Harvard University under Dr. Conor Walsh and is president and cofounder of EndoShunt Medical, which develops an endovascular device for hemorrhage control in traumatic injuries.

Jeremy LevinNamed on SEC filing

Board

Milad BehbahaniniaMember of Board of Directors

Olivia BuskMember of Board of Directors

Investors · 3

New York Angelslisted by New York AngelsNew York · $100K – $1.5M

How we know: New York Angels's portfolio page · the VCSheet dataset · Not right? Tell us

Octerra Capitallisted by Octerra CapitalLagos

How we know: Octerra Capital's portfolio page · Not right? Tell us

The Innovation Spacelisted by The Innovation SpaceWilmington · $200K

How we know: The Innovation Space's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$75K disclosed across 1 round · 2022

▶$75KraisedNov 2022 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jeremy LevinDirector
Milad BehbahaniniaDirector
Olivia BuskDirector
Michael Finn-HenryExecutive Officer, Director

Offering amount: $75K
Amount sold: $75K
First sale: Nov 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Endoshunt went on to found or lead other companies.

Haven AllenBoard ObserverFounded mHUB Michael NagelChairperson of the BoardFounded Raydiant Oxymetry

Frequently asked questions

What does Endoshunt do?: EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip. The company has functional prototypes validated in benchtop and in vivo studies and is pursuing FDA 510(k) clearance.
Who founded Endoshunt?: Endoshunt was founded by Michael Finn-Henry in 2022.
Who are Endoshunt's investors?: Endoshunt's investors include New York Angels, Octerra Capital, The Innovation Space.
How much funding has Endoshunt raised?: Endoshunt has disclosed $75K raised across 1 round.
Where is Endoshunt headquartered?: Endoshunt is headquartered in Lincoln, US.